Mucous Membrane Pemphigoid Treatment Market – Future Scenario, Key Insights, Top Companies 2028

Mucous membrane pemphigoid is a group of rare and chronic autoimmune diseases which are characterized by blistering on the various mucous layers of the body. Mucous membranes of mouth, nose, throat, and eye are often affected by the mucous membrane pemphigoid. In June 2018, FDA approved Genentech’s rituxan, first treatment in more than 60 years for the treatment moderate to severe pemphigus vulgaris (PV). The manufacturers in mucous membrane pemphigoid treatment market are focusing on the developing new and effective formulations. Being a rare disease, mucous membrane pemphigoid treatment market offers limited patients pool for the treatment and hence manufacturers are developing new formulation by keeping an eye on the overall potential economic return as well as development expenditure. The incidence of mucous membrane pemphigoid varies widely, for example, the incidence of mucous membrane pemphigoid U.K. is 1 in million population whereas in Germany and France the incidence is 2 in million population. Although the difference in the incidence does not look vast but considering it as a rare disease it varies widely.

Mucous Membrane Pemphigoid Treatment Market: Drivers and Restraints

The average age of onset of mucous membrane pemphigoid is 60 years and hence the ageing population of the world expected to result in increased incidence of the disease driving the growth of the mucous membrane pemphigoid treatment market. The increasing availability of treatment option further expected to fuel the growth of the mucous membrane pemphigoid treatment market. The increasing rate of diagnosis due to improving awareness about the disease further expected to enhance treatment-seeking rate, in turn, driving the growth of mucous membrane pemphigoid treatment market. Manufacturers in the mucous membrane pemphigoid treatment market are focusing on product approvals and launches in the developed as well as developing world which expected to increase their geographical product footprint fueling the growth of the mucous membrane pemphigoid treatment market. Due to rare disease status, the disease, mucous membrane pemphigoid treatment options are given special status and exclusivity to encourage manufacturers to develop advanced mucous membrane pemphigoid treatment, in turn, driving the growth of the market. Whereas, limited awareness and low diagnosis rate in developing part of the world may hamper the potential growth of the mucous membrane pemphigoid treatment market.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-8908

Mucous Membrane Pemphigoid Treatment Market: Overview

The mucous membrane pemphigoid treatment mainly is driven by the increasing treatment-seeking rate and increased awareness. The mucous membrane pemphigoid treatment market by drug class is expected to be dominated by monoclonal antibodies due to their high efficacy in mucous membrane pemphigoid treatment. The global mucous membrane pemphigoid treatment market by route of administration is expected to be dominated by injectables due to high therapeutic bioavailability in the blood and effective delivery of drugs. The global mucous membrane pemphigoid treatment market by distribution channel is expected to be dominated by the retail pharmacies due to high patient footfall.

Mucous Membrane Pemphigoid Treatment Market: Regional Outlook

The global mucous membrane pemphigoid treatment market is expected to be dominated by North America due to the high prevalence of the disease as well as high treatment-seeking rate. Europe is expected to be the second most lucrative mucous membrane pemphigoid treatment market due to increasing product adoption for the treatment. Latin America mucous membrane pemphigoid treatment market is expected to witness a steady rise in the revenues generation due to increasing product availability. The Asia-Pacific mucous membrane pemphigoid treatment market is expected to be an emerging market due to rapidly increasing awareness about the disease and product availability. MEA mucous membrane pemphigoid treatment market is expected to be least lucrative market due to low product adoption.

Mucous Membrane Pemphigoid Treatment Market: Key Players

The key players operating in the global mucous membrane pemphigoid treatment market are: Genentech, Inc., EPI Health, LLC., Pfizer Inc., Astellas Pharma US, Inc., Actavis Plc., Lipidor AB, SUN PHARMA company, Merck Sharp & Dohme, GlaxoSmithKline plc., Bausch Health and others

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-8908

Why Future Market Insights?

  •   Comprehensive analysis on evolving purchase pattern across different geographies
  •   Detailed insights of market segments and sub-segments for historical as well as forecast period
  •   A competitive analysis of prominent players and emerging players in the keyword market
  •   Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:
Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Drainage Catheter Market Key Players – Teleflex, Smiths Medical, Medtronic, Atrium, Redax, Medela, Sorin, Argon, PAHSCO, Cook Medical, Atmos & Diversatek

Drainage Catheter Market: Overview

Drainage Catheter is observably used more in chest applications, to remove the excess fluid deposition. The market in respect to that would be more as compare to other applications. Expansion of Drainage Catheter market is dependable with the present disease indications. Future technological advancements and cost reduction would help in sales growth. Increase in operating profits would be dependent on the manufacturing cost and marketing cost. More awareness for each breakthrough product would shift the market dynamics leading to more a fragmented and open market space. Catheters in general has a broad spectrum of applications and with frequent market advancements it is projected to mark a positive framework for new businesses. Drainage catheter is one such type that is high in demand for its clinical benefits, currently the market structure for the concerned Drainage Catheter is less fragmented but emergence of new players is anticipated.

Drainage Catheter is used to remove excess fluid which gets deposited in sections of the body. The procedure involves an insertion through the skin into the area where fluid has accumulated. Drainage catheter is then used to drain out the fluid into a drainage bag. Drainage Catheter is used in most part of the body where such scenario takes place. There are factors that needs to be addressed before the surgery.  The procedure of fluid removal with a drainage catheter is highly used in radiology services, and as per the American Cancer Society, the number of incidence cases for lung cancer were approximately around 228,150 for 2019 in the United States.

Drainage Catheter Market: Drivers and Restraints-

Incidence of cancer is reportedly rising in countries with unhealthy lifestyle trend and their natural surrounding which is prone to such driving situations. The adoption of catheters and equal advancements has led a revolutionary trend in product developments. Exodus from Navilyst Medical, Inc. is industry’s first co-extruded drainage catheter, it allows a measurably better column strength and flow rate.

The removal of excess fluid is also a therapy in cases like athologic abdominopelvic and biliary ?uid collection which drives the market with present reported cases. The increase in target population among global population pushes the market to new boundaries. Companies working in overall catheter industry are trying to penetrate the growing market of drainage catheter. Cost reduction in most minimally invasive products is a highlight for this industry encouraging other new entrants. Reimbursements for procedure carried by a drainage catheter is present in most developed countries, also shifting the scenario to emerging countries with blooming healthcare facilities

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-9303

Drainage Catheter Market: Region-wise Outlook

North America and Europe’s Drainage Catheter market is expected to take the maximum market share, owing to the innovations and key manufacturers present in the region. Healthcare cost is more in those regions as compare to other developing regions like India and China. Though, the Drainage Catheter market attractiveness for such developing regions offer a high growth rate.  East Asia Drainage Catheters market is subjected to grow with the highest growth rate due to high prevalence rates and regional manufacturer’s presence. In general the global market would increase significantly during the forecast period, because of the growing awareness, rise in geriatric population and high incidence rates due to increased lifespan regions.

Drainage Catheter Market: Key Market Participants

Some of the Drainage Catheter market participants in the global Drainage Catheter market identified across the value chain include: Teleflex, Smiths Medical, Medtronic, Atrium, Redax, Medela, Sorin, Argon, PAHSCO, Cook Medical, Atmos & Diversatek.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

The report covers exhaust analysis on:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Regional analysis includes:

  • North America (U.S., Canada)
  • Latin America (Mexico. Brazil)
  • Europe (Germany, Italy, France, U.K, Spain, Russia, Benelux)
  • South Asia (India, Thailand, Malaysia, Indonesia)
  • East Asia ( China, Japan, South Korea )
  • Oceania ( Australia, New Zealand )
  • Middle East and Africa (GCC Countries, S. Africa, Northern Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-9303

Drainage Catheter Market: Segmentation

On the basis of product type, Drainage Catheter Market can be segmented as:

  • J-Tip
  • Standard Loop
  • Tight Loop

 On the basis of application type, Drainage Catheter Market can be segmented as:

  • Chest Drainage Catheter
  • External Ventricular Drainage Catheter
  • Other

On the basis of end user, Drainage Catheter Market can be segmented as:

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Center

Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current, and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-9303

Microbial Therapeutic Products Market 2021 Key Players, SWOT Analysis, Key Indicators, Forecast To 2031

Future Market Insights’ (FMI) global microbial therapeutic products report provides an exhaustive yet unbiased analysis of future growth projections, taking into account the aforementioned developments to provide a bird’s eye view of the landscape. According to the study, demand for microbial therapeutic products is likely to grow at a steady clip, driven chiefly by growing incidence of antimicrobial resistance.

Over the years, the burden of antimicrobial resistance (AMR) has been escalating tremendously, besides prevalence of chronic conditions. The World Health Organization observes high resistance rates have been observed against antimicrobials used for treating urinary tract infections and certain types of diarrhea. For example, the rate of resistance to ciprofloxacin ranged anywhere between 8.4% and 93% across 33 countries. It is apprehended that this burden is compounding further due to the COVID-19 pandemic. Hence, efforts are underway to accelerate research for discovering breakthroughs in microbial therapeutics.

To Get Sample Copy of Report visit @ https://www.futuremarketinsights.com/reports/sample/rep-gb-12891

Key Takeaways

  • By product, anti-cancer agents to capture nearly 30% revenue by 2020-end, owing to prolific research breakthroughs
  • By route of administration, injection pens to account for 2 out of 5 sales, attributed to patient hygiene concerns
  • By source, bacteria based microbial therapeutic products to remain preferred
  • Oncology to remain primary microbial therapeutic products application area, expanding at Y-o-Y rate exceeding 5% through 2020
  • Hospitals emerge as the primary microbial therapeutic end-users, attributed to availability of adequate infrastructure
  • North America to remain the market hegemon, East Asia to be fastest growing market

“Prominent manufacturers are seeking regulatory approvals to accelerate research and development operations for developing effective drug solutions to address the compounding antimicrobial resistance problems,” remarks the FMI analyst.

COVID-19 Impact Analysis

The COVID-19 pandemic has adversely impact global economic outlook, with a prolonged recession on the cards across numerous industries. However, the microbial therapeutic products market has only stood to benefit from the pandemic crisis, as the global healthcare community accelerates efforts to find a potential cure for this deadly virus.

With inoculation procedures already being initiated across the U.K., it is only a matter of time before the anti-COVID-19 vaccine is available on a global scale. Despite this availability, healthcare providers will have a long road ahead with respect to discovering an orally administered drug formulation.

Therefore, governments are lending unconditional support to the global healthcare fraternity in terms of policy relaxation and disbursement of financial grants to aid in the research and development process, catapulting growth prospects.

Competitive Landscape

Prominent players operating in the global microbial therapeutic products market are emphasizing on acquiring regulatory approvals, forging partnerships and collaborations with competent authorities and biosimilars develop to capture substantial revenue shares across key regions.

Some reputed players operating within the global microbial therapeutic products landscape include Dr. Reddy’s Laboratories, Pfizer Inc., Sanofi SA, Merck & Co. Inc., Novartis AG, Novo Nordisk A/S, Abbott Laboratories and Amgen Inc. to name a few.

In November 2020, Dr. Reddy’s Laboratories announced a definitive agreement with Glenmark Pharmaceuticals Ltd. to acquire its anti-allergy brands Momat Rino, Momat Rino Advance and Momat A to market them across Russia, Kazakhstan and Uzbekistan respectively.

In December 2020, Novo Nordisk announced the acquisition of Emisphere Technologies to exercise ownership of its Eligen SNAC oral delivery technology. The acquisition shall accelerate its GLP-1 receptor agonist seaglutide’s production on a larger scale.

For Complete TOC @ https://www.futuremarketinsights.com/toc/rep-gb-12891

More Valuable Insights on FMI’s Microbial Therapeutic Products Market

Future Market Insights, in its new report, offers an unbiased analysis of the global microbial therapeutic products market, analyzing historical demand from 2015-2019 and forecast statistics for 2020-2030. The study reveals growth projections on the microbial therapeutic products market on the basis of product (growth factors, anti-cancer agents, immunosuppressants, enzymes & others), route of administration (single use pre-filled injection/injection pen, multi-use injectors & others), source (bacteria & fungi), application (metabolic disorders, haematological disorders, oncology, immunological disorders, infectious diseases, allergic diseases & others) and end-user (hospitals, pharmaceuticals & biopharmaceutical companies and research & academic institutions) across seven prominent regions.

Autoclaves Market Emerging Trends, Size, Share and Growth Analysis by 2031

The global autoclaves market will exhibit 5% CAGR between 2020 and 2030, especially as demand for sterilization and disinfections continue rising across hospitals, academic and research institutes, biopharmaceutical companies, and other facilities, finds Future Market Insights (FMI) in a new study. As per the report, increasing cases of hospital acquired infections will encourage investment in autoclaves across healthcare facilities.

According to the Centers for Disease Control and Prevention (CDC), on any given day, about 1 in 31 hospital patients has at least one health-care associated infection. Autoclaving destroys microorganisms with higher efficiency than dry heat. Hence autoclaves are registering increasing applications in the healthcare industry.

While the outbreak of novel coronavirus has taken a toll on the market affecting its growth, it is recovering steadily to bounce back. Patient admissions in hospitals and other healthcare facilities has increased, which is in turn fuelling the demand for autoclaves in the recent year.

FMI offers an in-depth analysis and overview of the global autoclaves market, covering factors enabling its growth, creating prospects, and key threats.

To Get Sample Copy of Report visit @ https://www.futuremarketinsights.com/reports/sample/rep-gb-12890

Some of the key takeaways from the report are highlighted below-

  • Rise in demand for gravity autoclaves is projected to fuel the growth of the market during the forecast period between 2020 and 2030
  • Floor standing autoclaves will gain traction due to the high for laboratory applications
  • The demand for front loading type autoclave is expected to be higher than top loading and pass through
  • Cylindrical autoclaves will be highly sought-after among chamber types
  • Academic and research institutes will continue exhibiting high demand for autoclaves
  • North America will dominate in the global market followed by Europe

“The rising awareness among the hospital staff, doctors, and patients regarding the hospital acquired infections is spurring the growth of the autoclaves market. The outbreak of COVID-19 pandemic has resulted in unbridled rise in patient pool across hospitals and healthcare centers, increasing the risk of hospital acquired infections. According to the National Centre for Biotechnology Information (NCBI), the risks of Central Line-Associated Bloodstream Infection (CLABSI), Catheter Associated Urinary Tract Infection (CAUTI), and others are higher in COVID-affected patients. This has been fuelling the demand for autoclaves and the trend is expected persist over the next couple of years,” says an FMI analyst.

COVID-19 Impact Analysis

The outbreak of COVID-19 pandemic caused decline in the growth of market earlier this year. The sudden lockdown, coupled with restrictions imposed, had severely affected manufacturing units of the autoclaves. However, autoclaves being an integral part of the sterilization process started experiencing surge in demand soon after getting over the temporary period of lull. The ongoing pandemic has resulted in higher requirement for sterilized and clean environment across healthcare facilities, which is substantially pushing the demand curve for autoclaves upward. As per Medical Product Outsourcing (MPO), autoclaves are staples in the healthcare industry and they are used extensively for high-pressure steam sterilization on various tools and industrial components, especially during COVID-19 pandemic.

According to the World Health Organization (WHO), biosafety levels BSL-2 and BSL-3 are required in order to handle COVID-19 by maintaining clean and safe environment. As laboratory autoclaves are ideal for sterilization of contaminated instruments, waste, laboratory equipment, and others while maintaining these standards, they are highly required in diverse end-user industries starting from pathology laboratories to academic and research institutes.

Who is Winning?

Competition in the global autoclaves market has been rising steadily. In order to strengthen their foothold, market players are focusing their efforts towards exploring and capitalizing on new opportunities. This has resulted in a slew of product launches in the last few years.

For instance, Benchmark Scientific has launched their new range of BIOCLAVE™ RESEARCH AUTOCLAVES which are designed specifically for laboratory research tools and provide fully automatic services in the current year.

Panasonic Biomedical has launched their new extensive range of laboratory autoclaves such as MLS-3020U, MLS-3751L, MLS-3781L, and others in the recent year.

For Complete TOC @ https://www.futuremarketinsights.com/toc/rep-gb-12890

More Valuable Insights on Autoclaves Market

In the latest report by Future Market Insights, we offer an unbiased analysis of the global autoclaves market, providing historical data for the period of 2015-2019 and forecast statistics for the period of 2020-2030. In order to understand the global market potential, its growth and scopes, the market is segmented on the basis of product (gravity autoclave, vacuum-induced autoclave), modality (floor standing, bench top, wall mounted, portable), loading type (top loading, front loading, pass through), chamber type (cylindrical, rectangular), end user (hospitals, office based clinics, academics and research institutes, research laboratories, pathology laboratories, biopharmaceutical companies, food and beverage companies), across six major regions (North America, Latin America, Europe, South Asia, East Asia, Oceania, MEA).

Transradial Closure Devices Market Outlook On Emerging Application, Revolutionary Trends & Potential Growth Strategies 2031

The transradial closure devices market is growing with the increasing cases of cardio vascular diseases all over the world. A new study by Future Market Insights (FMI) has projected the market to rise at 6.5% CAGR between 2020 and 2030. According to the report, demand will rise consistently on the back of surging cases of cardiovascular ailments caused by stress, unhealthy lifestyle, and others factors.

According to World Health Organization (WHO), every year cardiovascular diseases cause an estimated 31% of death occurring worldwide. Also a 2016 Heat Disease and Stroke Statistics update by the American Heart Association stated that over 15 million people in the U.S. have coronary heart disease.

With no signs of the incidence slowing down, the demand for procedures such as angiography, angioplasty, percutaneous coronary intervention (PCI), and others will continue rising. Consequently, the demand for transradial closure devices is surging rapidly all over the world.

Radial access is highly efficient in providing faster mobility to patients due to smaller incision.  Furthermore, chances of infection at site is lower in radial access as compared to transfemoral access, which makes it highly preferred by diverse end users, starting from hospitals to specialized clinics.

To Get Sample Copy of Report visit @ https://www.futuremarketinsights.com/reports/sample/rep-gb-12841

The outbreak of COVID-19 pandemic is anticipated to impact the market negatively. The temporary period of lull could continue until the next year. However, the transradial closure devices market has high potential to grow further in the coming years.

FMI offers an exhaustive overview of the transradial closure devices market, its growth drivers, and restraints.

Some of the key takeaways from the report are highlighted below-

  • Band or strap based transradial closure type devices are expected to lead in the market during the forecast period
  • Disposable devices are anticipated to gain traction in terms of usage
  • Application of transradial devices in diagnostic segment will remain high throughout the forecast period
  • Among the end users, independent catheterization centres will emerge dominant in the coming years
  • North America will lead in the global market followed by Europe

“Due to the rising cases of cardio vascular diseases, there has been increase in surgical and diagnostic procedures related to it. Transradial access (RA) being associated with less complications, is highly preferred by the various end users such as ambulatory surgical centers, hospitals, and others. In the coming years, the uptake of transradial closure devices will therefore rise especially since patients are increasingly willing to spend on procedures that ensure shorter hospital stays,” says an FMI analyst.

COVID-19 Impact Analysis

Due to the outbreak of COVID-19 pandemic, manufacturing process of transradial closure devices was hampered during the lock down. Contrary to this, novel coronavirus might cause cardiovascular concerns, which has resulted in surge in demand for the transradial closure devices in hospitals, specialized clinics, and other segments.

As per the latest study by FMI, the global transradial closure devices market has high potential to overcome the threats posed by the ongoing pandemic and grow further in the coming years.

Who is Winning

The global transradial closure devices market is highly competitive. In order to strengthen their foothold market players are focusing on the launch of ultra-modern transradial closure devices.

For instance, Comed B.V has launched their new Io™ Radial Compression Tourniquet (Io™ RACT) which is effective to compress the radial artery puncture, post procedure in the current year. Their Io™ RACT is small, and especially designed to optimize compression, view the puncture side and deflate the compression balloon.

Merit Medical, Inc. has launched their exclusive PreludeSYNC™ Radial Compression Device which assists in achieving vascular hemostasis in the recent year. Their PreludeSYNC™ Radial Compression Device is available with the safety and convenience of a specialized connection device and syringe.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-12841

More Valuable Insights on Transradial Closure Devices Market

In the latest report by Future Market Insights, we offer an unbiased analysis of the global transradial closure devices market, providing historical data for the period of 2015-2019 and forecast statistics for the period of 2020-2030. In order to understand the global market potential, its growth and scopes, the market is segmented on the basis of product type (band/strap based, knob based, plate based), usage (disposable device, reusable device), application (surgical intervention, diagnostics), end user (hospitals, independent catheterization centers, ambulatory surgical centers, specialized clinics), across six major regions (North America, Latin America, Europe, South Asia, East Asia, Oceania, MEA).

Fiducial Markers Market Study For 2020 To 2031 Providing Information on Key Players, Growth Drivers and Industry Challenges

Future Market Insights (FMI) has recently published an exhaustive yet unbiased study on the global fiducial markers market elaborating on the vital dynamics responsible for shaping future growth trajectory for the forecast period ranging from 2020-2030.

According to the American Cancer Society, in 2019, approximately 174,650 men were diagnosed with prostate cancer, up by 6% from 2018. It is also the second leading cause of deaths among American men, with over 33,000 fatalities expected by 2020-end.

Therefore, manufacturers are likely to find immense opportunities with respect to introducing fiducial markers to aid in eradicating this deadly disease across potential regions. Recent research has paved the way for non-implantable fiducial markers using the cone-beam CT technology.

To Get Sample Copy of Report visit @ https://www.futuremarketinsights.com/reports/sample/rep-gb-12825

Key Takeaways

  • Global fiducial markers market to reach US$ 258.8 Mn by 2030, expanding at over 8% CAGR
  • Pure gold fiducial markers to capture lion’s share, expected to generated over 60% revenue by 2020-end
  • By modality, photon treatment is expected to generate an absolute opportunity worth US$ 12 Mn through 2030
  • Maximum uptake likely across the prostate cancer segment, accounting for over 7 out of 10 fiducial marker applications
  • Radiotherapy centers to remain primary end-users of fiducial markers due to deployment of specialized cancer treatments
  • Europe and North America to capture an impressive market share, East Asia following closely

“Increasing research and development for discovering technologically advanced solutions to treat cancers and other debilitating disorders is generating immense green space for potential fiducial markers market players,” says the FMI analyst.

COVID-19 Impact Analysis

The COVID-19 pandemic has widened growth prospects for the global fiducial markers market. As cancer treatment acquires precedence, healthcare providers are making accommodations to address patients suffering from debilitating conditions. Consequently, the need for precision-based detection systems has aggrandized in recent months.

Amid strict hygiene and social distancing protocols, healthcare providers are conducting radiation and chemotherapy procedures, leading to increased uptake of fiducial markers. Moreover, to reduce infection risks, patients requiring immediate surgical care are attended to first while consultation for possible prevalence have been shifted to virtual platforms.

Competitive Landscape

The global fiducial markers market comprises of the following prominent players: Eckert & Ziegler BEBIG, Innovative Oncology Solutions, Boston Scientific, IBA Dosimetry, Best Medical International, Inc., Carbon Medical Technologies, CIVCO, alphaXRT, Nanovi A/S, and Stellar Medical to name a few.

A combination of expansion strategies, ranging from new product launches to strategic collaborations and alliances and technological disruptions are employed by these manufacturers to stay afloat in this highly competitive environment.

Innovative Oncology Solutions, for instance, markets the FLEXIMARC G/T Specialty Fiducial Markers, consisting of two 1.2 mm x 3 mm gold nodes separated by a thin, medical grade titanium filament which is optimized for MRI visibility. This permits soft tissue to anchor the marker in place, reducing chances of migration.

With regard to technological advancements, IBA Dosimetry announced the launch of its myQA iON radiation therapy integrated quality assurance (QA) platform in 2019. This platform incorporates process automation, task-based workflows and PT machine log files to streamline cancer treatment procedures.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-12825

More Insights on FMI’s Fiducial Markers Market Report

Future Market Insights, in its new report, offers an unbiased analysis of the global fiducial markers market, analyzing historical demand from 2015-2019 and forecast statistics for 2020-2030. The study reveals growth projections on the fiducial markers market on the basis of product (polymer based markers, metal based markers, pure gold markers and liquid based markers), modality (photon therapy, proton therapy, tomotherapy and cyberknife), disease site (head & neck, breast, lung, abdomen, prostate, kidney, cervix or other gynecologic organs) and end-user (hospitals, cancer research institutes and radiotherapy centers) across seven prominent regions.

Glycoprotein Analysis Market Analysis, Segments, Growth and Value Chain 2020-2031

Glycoprotein is the proteins with oligosaccharide moieties which emerge after glycosylation during post-translational or co-translational modification of proteins.

Glycoprotein plays a crucial role in cellular metabolism and functions including cell signalling, cellular adhesion, immune system, pathogenicity, genesis and progression of metabolic disease and biomarker of diseases such as cancer.

There Glycosylations are of two types, O-glycosylation on Serine (Ser) or Threonine (Thr) residues and N-glycosylation on Aspargine (Asn) residue with the consensus sequence of Asn-X-Ser, where X is any amino acid except proline (Pro).

Glycoprotein analysis can be instrumental for understanding its structure and function and its role in the underlined diseases prognosis and their therapy. The global glycoprotein analysis market is anticipated to grow with the advancing research of glycoprotein into chronic diseases.

Coronavirus has leveraged the global glycoprotein analysis market growth. Coronavirus glycoprotein coat is actively dwelled to decode the pathogenicity and develop vaccine or therapies for the novel-virus.

Request for Report brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-12692

Immunoblotting analysis, epitope mapping, chromatography, spectrometry and many others are actively implemented for research and glycoprotein analysis

Glycoprotein Analysis Market: Drivers and Restraints

The global glycoprotein analysis market driver includes the massive research and technology for glycoprotein analysis to unravel their structure and function. Glycoprotein analysis has a huge market base in food consumption bacterial and yeast protein production and healthcare.

Also the advancing R&D technology and investments into glycoprotein analysis for drugs therapies vaccines disease progression understanding the biology of glycoprotein and product launches.

Glycoprotein analysis is has massive rseaech involvement into cancer of breast prostate and ovary malfunctioning glycoprotein associated enzyme and metabolism aberrations resulting in glycoprotein storage diseases including Alpha-Mannosidosis Aspartylglucosaminuria and Beta-Mannosidosis.

Glycoprotein analysis has attracted huge R&D investments subsidization and reimbursements for glycoprotein associated antibodies mutations and associated pathway targeting which altogether propels the glycoprotein analysis market growth.

However the smooth growth of glycoprotein analysis market is halted due to low abundance of native target glycoproteins purification enrichment and fractionation issues simultaneous glycoprotein sequencing glycan moieties and glycosylation sites analysis.

Glycoprotein analysis gets complex due to the increasing heterogeneity of glycan structures. Glycoprotein analysis requires further sensitive and quantitative methods for the urgent detection of specific glycoform and its role in disease progression.

Glycoprotein analysis techniques such as spectroscopy and chemical reagents are expensive labour-intensive and the dearth of research and medical professionals decelerates the growth of glycoprotein analysis market.

Despite these constraints global glycoprotein analysis market is poised to grow lucratively due to the progressing R&D and healthcare and investments driven by the vast application of glycoprotein in healthcare and food.

The novel analysis methods with improved accuracy sensitivity and efficacy and cost-effectiveness which will  propel the global glycoprotein analysis market furthermore.

Glycoprotein Analysis Market: Overview

The global glycoprotein analysis market is growing lucratively with the technological advancements of glycoprotein analysis for research healthcare and food. By glycosylation the global glycoprotein analysis glycosylation is divided into N-linkage and O-linkage which have a crucial role in the progression and therapy of several diseases.

N-glycosylation plays crucial role in arthritis cancer diabetes Crohn’s diseases and several nervous system diseases. N-linked glycoprotein is found in therapeutic antibodies including Rituximab Etanercept and Infliximab. O-glycosylation is involved in antibody structure analysis and development targeting of Alzheimer diseases and cancers by O-glycan structure and terminal Lewis epitopes.

By end-users the global glycoprotein analysis techniques have major contributions from hospital and research institutes and their collision for glycoprotein associates diseases diagnosis and analysis. The glycoprotein analysis data from research institutes are crucial for the diagnosis.

By techniques mass spectrometry dominates the glycoprotein analysis technique due to their sensitivity specificity speed and stoichiometry for the glycoprotein identification glycosylation site and glycan structures.

Major spectrometry techniques for glycoprotein analysis include mass spectrometry (MS) Electrospray ionization mass spectrometry (ESI-MS) matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) and hydrophilic interaction chromatography-mass spectrometry (HILIC-MS).

Glycoprotein Analysis Market: Regional Outlook

North America holds the largest global glycoprotein analysis market with its advanced R&D pharmaceutical development and research healthcare expenditure and investments which are supported by the government research institutes hospitals and other organizations for disease diagnosis therapy and glycoprotein food industry and key players.

Europe holds the second largest global glycoprotein analysis market with its advanced research and healthcare government’s support numerous start-ups and leading companies.

Asia-pacific glycoprotein analysis market is growing at the fastest pace fuelled by the advancing research institutes and hospitals progressing pharmaceuticals and glycoprotein analysis and production. Latin America glycoprotein analysis market is growing gradually with improving R&D and healthcare.

MEA& Africa glycoprotein analysis market is growing laggardly due to the technological backwardness although South-Africa and Israel with their advancing research and growing protein industry are expected to push the growth of regional glycoprotein analysis market

Glycoprotein Analysis Market: Key Players

The key players of the global glycoprotein analysis market include

  • Sigma-Aldrich. BD
  • Enzo Life Sciences
  • Creative Diagnostics
  • Thermo Fisher Scientific
  • Epitope Diagnostics Inc.
  • R&D Systems
  • QED Bioscience Inc
  • ACROBiosystems.

The research report presents a comprehensive assessment of the market and contains thoughtful insights facts historical data and statistically supported and industry-validated market data.

It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies application and industry.

The report covers exhaust analysis on:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Indication
  • Value Chain

Regional analysis includes:

  • North America (U.S. Canada)
  • Latin America (Mexico. Brazil)
  • Europe (Germany U.K France Italy Spain)
  • South Asia (India ASEAN Countries)
  • East Asia (Japan China & South Korea)
  • Oceania (Australia & New Zealand)
  • Middle East and Africa (GCC Countries South Africa Northern Africa)

The report is a compilation of first-hand information qualitative and quantitative assessment by industry analysts inputs from industry experts and industry participants across the value chain.

The report provides in-depth analysis of parent market trends macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-12692

Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint

Glycoprotein Analysis Market: Segmentation

The global glycoprotein analysis market is segmented into glycolysation, end-users, techniques and regions.

By glycolysation

  • N-linkage
  • O-linkage

By end-users

  • Hospital
  • Research Institutes
  • Others

By techniques

  • Molecular Reagents
  • Mass Spectrometry

Non-Surgical Fat Reduction Market 2021 Industry Analysis by Type, Application, End-User and Region

Non-surgical fat reduction is a minimally invasive treatment of body fat reduction. Non-surgical fat reduction is conducted through various technologies including heat, cooling, medication and injectable. Non-surgical fat reduction is performed with variety of devices, including radio frequency, infrared light, ultrasound, and injectable medication. The global non-surgical fat reduction market is expected to reach a value of US$ 220.0 Mn by the end of 2022, according to a latest research by Future Market Insights (FMI). The report on the non-surgical fat reduction market further projects significant growth potential with average year-on-year growth rate of 5.1% through 2022.

Obesity leads to serious health problems including heart disease, high blood pressure, diabetes, and cancers in certain cases. Excess deposition of body fat triggers insulin production, which lead to diabetes. According to a study conducted by Harvard, the risk of diabetes is 20 times more in obese population. This also increases the risk of high blood pressure, gallstones and stroke. The growing number of obese population is seeking for cost-effective, less painful non-surgical fat reduction procedures, which can be performed at outpatient centres or beauty clinics. Some of the most popular procedures among non-surgical fat reduction are injection lipolysis, cryolipolysis, laser lipolysis, and radiofrequency lipolysis.

Click the link to get a free Sample Copy of the Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-5321

The non-surgical fat reduction market is predominated by few companies that are offering their approved products to the end users. These companies are competing in the non-surgical fat reduction market through product differentiation strategy. The leading players operating in the market have varied range of products, which operate on different technologies. Non-surgical fat reduction is gaining popularity among teen-age groups. According to the American Society of Plastic Surgeons (ASPS), approximately 229,000 cosmetic procedures were conducted on teen-aged patients (age 13 to 19) in 2017. The prime reason behind the increased number of plastic surgeries among teen-age group is social media-obsessed culture, where teenagers opt for various type of plastic surgery. The increasing number of teen-age population across beauty clinics is likely to boost the growth of Non-surgical fat reduction market.

Non-surgical fat reduction is gaining popularity among women who have undergone C-section during their pregnancy. This patient population is seeking for body-contouring treatments for their post-pregnancy marks. Non-surgical fat reduction is a cost-effective solution for body-contouring women. Non-surgical fat reduction techniques available in the market are also targeting population that are looking for temporary fat reduction solution. In order to cater the demand, Syneron Medical Ltd (UltraShape) & Valeant Pharmaceuticals International, Inc. (Liposonix) are offering FDA approved products for ultrasound fat reduction treatment. The devices offered by the companies use focused ultrasonic waves to break the fat while leaving surrounding tissues unharmed. Non-surgical fat reduction with laser-based technology is adopted by patient looking for fat reduction in particular areas such as hips, waist and thighs.

Most of the surgeons does not recommend laser-based surgery for pregnant mothers, or women trying to conceive or for people with pacemakers. Based on the product type, the laser-based devices segment is expected to account a high share in the global non-surgical fat reduction market in terms of value throughout the forecast period. Moreover, this segment is projected to register a CAGR of 5.6% through 2022.

FMI has segmented the global non-surgical fat reduction market based on product type, end users, & regions. In terms of revenue, the beauty clinics end-user segment holds substantial share in the non-surgical fat reduction market and is expected to gain momentum over the forecast period due to increasing awareness regarding cost-effective non-surgical fat reduction procedures.

Examples of some of the companies profiled in the report are Cutera Inc., Syneron Medical Ltd., Lutronic Corporation, Fotona d.d., Cynosure, Inc., Solta Medical Inc., Lynton Lasers Ltd., Alma Lasers, Ltd., Venus Concept Canada Corp., EL.En. S.p.A., and Sciton, Inc.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-5321

Additional Questions Answered

Some of the additional questions addressed in the report for Non-Surgical Fat Reduction market-

  • What is role of regulatory authority and plastic surgery service providers in market?
  • What is the revenue potential of Non-Surgical Fat Reduction over conventional invasive fat reduction procedures?
  • How Non-Surgical Fat Reduction market is gaining momentum in Asia region?
  • Who are the key competitors and what are their portfolios in Non-Surgical Fat Reduction market?
  • What is the price point for Non-Surgical Fat Reduction devices in developed countries?
  • What is the current level competition in the Non-Surgical Fat Reduction market?

PD-L1 Biomarker Testing Market SWOT Analysis, by Key Players

As the prevalence of lung cancer, melanoma, and renal cell carcinoma continues to soar worldwide, the adoption of PD-L1 biomarker testing is expected to grow at a healthy pace in the years to come, says Future Market Insights (FMI) in its new market study. Moreover, the report forecasts that the global PD-L1 biomarker testing market will grow in value at a stellar CAGR of 13.1% between 2020 and 2030.

The report opines that the outbreak of COVID-19 is likely to create short-term fluctuations on the supply side due to pandemic-related issues such as workforce shortages and disruptions of delivery networks. Similarly, a steep decline in the number of tests has been observed during the pandemic, and this is expected to further decelerate the demand for PD-L1 biomarker testing.

The report primarily attributes the growth of the market to the increasing incidence of cancers, especially lung and skin, coupled with the development of advanced diagnostic kits and assays.

Click the link to get a free Sample Copy of the Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-5897

Likewise, rising awareness regarding the availability of testing methodology such as immunohistochemistry-based assays and Enzyme-linked Immunoassay (ELISA) based detection will continue to impel the adoption of PD-L1 biomarkers in the forthcoming years.

Key Takeaways

  • The global PD-L1 biomarkers testing market is expected to surge past valuation of US$ 2.05 Bn by the end of the forecast period.
  • PD-L1 SP142 assay kits will remain the most popular products among end-users, capturing nearly half of the market value, owing to high efficiency in detecting cancer tumors.
  • Non-small cell lung cancer and melanoma are cumulatively expected to hold more than 50% of the total market value on the back of the soaring prevalence of these diseases.
  • By end-use, PD-lL1 biomarker testing finds the majority of applications in hospitals, which is expected to account for over 60% of market value.
  • North America will spearhead the regional landscape through the forecast period, accounting for more than 50% of the global market value.
  • Europe is poised to remain the second most lucrative region, holding nearly 1/3rd of market value.

“Market players are directing their efforts towards improving the accessibility of these products and are marking them cost-effective to ensure wide-scale adoption,” remarks FMI analyst.

COVID-19 Impact on PD-L1 Biomarker Testing Market

The COVID-19 pandemic has created disruptions across the healthcare technology landscape and has resulted in a shifting preference among manufacturers towards essential technologies and treatments. Furthermore, although PD-L1 biomarker testing is used to test severe diseases such as cancer, a reduced number of screenings is adversely impacting the demand for testing.

For instance, according to trends observed by Cancer Research Network, screening rates of melanoma plummeted by approximately 50% in the UK in the past few months. Likewise, in the US, the number of tests conducted to detect non-small cell lung cancer fell by 30% in March as compared to February. As patients reschedule or skip regular screenings, this is creating a downtrend in demand for PL-D1 biomarker testing.

However, considering the severity of these diseases, the need for testing will swiftly arise in the future, ensuring that the market’s growth trajectory remains intact.

Who is Winning?

Key players operating in the market are focusing on enhancing existing product designs and developing novel products with increased accuracy. Moreover, traditional growth strategies such as acquisitions and mergers have been identified as strategies adopted by players to strengthen their foothold in the competitive landscape.

  • In January 2019, Abcam Plc acquired Calico Biolabs with an objective to expand its custom monoclonal production service capabilities.
  • In December 2018, NeoGenomics, Inc. acquired Genoptix, Inc. to improve its oncology diagnostic services.

FMI’s report includes profiles of some of the most prominent names in the market including F. Hoffmann-La Roche Ltd, Agilent Technologies, Inc., NeoGenomics Laboratories, Inc, HalioDx and Abcam plc. among others.

For Complete TOC @ https://www.futuremarketinsights.com/toc/rep-gb-5897

To Know More About PD-L1 Biomarkers Market

A new market research report published by Future Market Insights (FMI) on the global PD-L1 biomarkers market offers an executive-level blueprint of the market. It offers insights into demand trends and provides analysis of opportunities over the forecast period, 2020-2030. The report examines the market through four different segments – product, indication, end-use, and region. The report also provides extensive assessment of pricing by different key market dynamics, life cycle analysis, and technologies that are being deployed in the supply and product adoption across several end-use industries.

Optical Coherence Tomography Market Trends, Business Outlook 2020, Expanding Current Industry Status by Top Most Players 2031

ESOMAR-certified consulting firm Future Market Insights’ report, projects a healthy growth, for optical coherence tomography (OCT) market. As per the report, the market is forecast to reach a valuation of US$ 1349.09 Mn over the forecast period of 2021 and 2031.

Growing application of OCT in ophthalmology across China, the U.K., Germany and Japan will bolster the demand of optical coherence tomography across the globe.

As per the FMI’s analysis, the optical coherence tomography market across Japan and China is anticipated to expand at over 9.8% and 4.6%, respectively in 2021. Growing prevalence of eye related disorders such as diabetic retinopathy, glaucoma and others will improve the adoption of OCT imaging systems.

Development of advanced OCT imaging systems coupled with increasing government & private organizations initiatives for eye care programs across the globe are propelling the adoption of OCT imaging systems.

To Get Sample Copy of Report visit @ https://www.futuremarketinsights.com/reports/sample/rep-gb-3362

Growing awareness and increasing innovation for the advanced OCT devices for the treatment of skin cancer and eye diseases have urged the manufacturers to incorporate real-time data for better outcomes, expanding their existing product ranges.

Based on the aforementioned factors, the OCT market is slated to expand at a robust pace of over 6.7% CAGR during the assessment period of 2021 and 2031.

Key Takeaways from FMI’s Optical Coherence Tomography Market Study

  • Hospitals are anticipated emerge as primary end users of optical coherence tomography market, accounting for leading market share
  • Preference for spectral domain-OCT will be higher as compared to swept source-OCT over the forecast period
  • Increasing application of OCT in ophthalmology is expected to drive sales through 2031
  • Germany and the U.K. will lead the Europe’s optical coherence tomography market on the back of rising cases of eye disorders across the region
  • Japan is anticipated to emerge as a lucrative market backed by the rising development of advanced OCT imaging systems within healthcare sector
  • China is anticipated to lead the East Asia market during the forecast period, accounting for over 4.6% market sales
  • The U.S. is estimated to be the largest market for optical coherence tomography market attributed to be growing prevalence of eye related disorders

“Key players are increasing research and development activities for the development of advanced OCT imaging system for the early detection & treatment of eye-related disorders. This, in turn, is likely to omprovegrowth opportunities for the market players over the coming years,” says the FMI analyst. 

Optical Coherence Tomography Market Competitive Landscape

Future Market Insights, in its updated report, have profiled prominent players operating in optical coherence tomography market which include Leica Microsystems, Optovue Inc., Carl Zeiss Meditec AG, Santec Corporation, Heidelberg Engineering GmbH, Optopol Technology SP Z.O.O., Topcon Corporation, Michelson Diagnostic Ltd., Tomophase Inc., Moptim Imaging Technique, NIDEK Co. Ltd., and Sonostar Technologies Co. Ltd among others.

Optical coherence tomography systems manufacturers are actively focusing on expanding their product portfolios to improve their revenue generation.

Incorporation of advanced technology combined with the upgradation of its existing range of products is also one of the core strategies of market players to maintain their position in the industry.

The global optical coherence tomography market is dominated by top tier-1 market players that include Leica Microsystem (Sub. Danaher), Optovue Inc., and Zeiss Group (Carl Zeiss Meditec AG).

Targeted mergers and collaborations with top distribution channel partners is anticipated to be the key strategy to maintain their top position in the industry. Around 20% to 25% of global market revenue is contributed by the tier-1 players over the forecast period.

New product launches with the expansion of their existing product range is one of the common market strategy for the key players. For instance:

In March 2021, Premier Medical Imaging AI Inc., a medical technology company focusing to transform cancer surgery with ultra-high resolution, announced the 510 (k) clearance for its Perimeter’s Optical Coherence Tomography imaging system (v2.1) from the U.S. Food & Drug Administration (FDA), designed to examine tissue microstructures during surgical procedures.

In January 2021, Notal Vision announced the launch of its first ‘US Home-Based’ optical coherence tomography platform which was patient self-operated.

To gain more insights into the market with a detailed table of content and figures, click here:  https://www.futuremarketinsights.com/toc/rep-gb-3362

More Insights on the Global Optical Coherence Tomography Market

Future Market Insights, in its latest report, offers an incisive coverage on the global optical coherence tomography market, providing historical data for the period of 2016-2020 and forecast statistics for the period of 2021-2031. In order to understand the global market potential, its growth, and scope, the market is classified on the basis of product type (spectral domain-OCT, swept source-OCT, and others), application type (ophthalmology, dermatology, cardiovascular, dental, and others), and end user (hospitals, ophthalmology clinics, dermatology clinics, dental clinics, ambulatory surgical centers, and others) across seven major regions (North America, Latin America, Eastern Europe, Asia Pacific excluding Japan, Western Europe, Japan and Middle East & Africa)